Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: Response to ribavirin therapy

55Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin. © 2000 Infectious Diseases Society of America.

Cite

CITATION STYLE

APA

Chakrabarti, S., Collingham, K. E., Holder, K., Oyaide, S., Pillay, D., & Milligan, D. W. (2000). Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: Response to ribavirin therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 31(6), 1516–1518. https://doi.org/10.1086/317482

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free